Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Environmental Science. Processes & Impacts
|
March 4, 2025
Seasonal variations in groundwater chemistry and quality and associated health risks from domestic wells and crucial constraints in the Pearl River Delta
Xingyu Zhou, Jia Sun, Hulong Yi, et al.
Diabetes, Obesity & Metabolism
|
January 6, 2026
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double-blind, placebo-controlled, ascending-dose phase 2a trial
Fei Gao, Mingxia Yuan, Nianrong Mi, et al.
The Canadian Journal of Cardiology
|
March 6, 2025
Using the QRS-V<sub>His</sub> Interval-based Algorithm to Optimize the Ablation Process of Outflow Tract Premature Ventricular Complexes
Linlin Wang, Lei Wang, Hailei Liu, et al.
Clinical and Translational Science
|
November 13, 2024
Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects
Jingcheng Chen, Jingxuan Wu, Nini Guo, et al.
Clinical and Translational Science
|
June 25, 2026
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants
Jingcheng Chen, Jingxuan Wu, Yuqin Song, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotency
Yanbo Zhu, Zi Yan, Changhao Fu, et al.
British Journal of Pharmacology
|
February 23, 2026
Development of a novel tyrosine kinase 2 inhibitor ARTS-011 and its first-in-human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
Zhili Jin, Jingxuan Wu, Jiaqi Liang, et al.
American Journal of Cancer Research
|
September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activation
Yuanyuan Nie, Lei Zhou, Hong Wang, et al.
Nature Communications
|
November 27, 2025
Odoribacter splanchnicus rescues aging-related intestinal P-glycoprotein damage via GDP-L-fucose secretion
Cheng Cui, Lu Fang, Lei Li, et al.
Scientific Data
|
November 21, 2018
Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming
Zhonghua Du, Lin Jia, Yichen Wang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Environmental Science. Processes & Impacts
|
March 4, 2025
Seasonal variations in groundwater chemistry and quality and associated health risks from domestic wells and crucial constraints in the Pearl River Delta
Xingyu Zhou, Jia Sun, Hulong Yi, et al.
Diabetes, Obesity & Metabolism
|
January 6, 2026
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double-blind, placebo-controlled, ascending-dose phase 2a trial
Fei Gao, Mingxia Yuan, Nianrong Mi, et al.
The Canadian Journal of Cardiology
|
March 6, 2025
Using the QRS-V<sub>His</sub> Interval-based Algorithm to Optimize the Ablation Process of Outflow Tract Premature Ventricular Complexes
Linlin Wang, Lei Wang, Hailei Liu, et al.
Clinical and Translational Science
|
November 13, 2024
Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects
Jingcheng Chen, Jingxuan Wu, Nini Guo, et al.
Clinical and Translational Science
|
June 25, 2026
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants
Jingcheng Chen, Jingxuan Wu, Yuqin Song, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotency
Yanbo Zhu, Zi Yan, Changhao Fu, et al.
British Journal of Pharmacology
|
February 23, 2026
Development of a novel tyrosine kinase 2 inhibitor ARTS-011 and its first-in-human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
Zhili Jin, Jingxuan Wu, Jiaqi Liang, et al.
American Journal of Cancer Research
|
September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activation
Yuanyuan Nie, Lei Zhou, Hong Wang, et al.
Nature Communications
|
November 27, 2025
Odoribacter splanchnicus rescues aging-related intestinal P-glycoprotein damage via GDP-L-fucose secretion
Cheng Cui, Lu Fang, Lei Li, et al.
Scientific Data
|
November 21, 2018
Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming
Zhonghua Du, Lin Jia, Yichen Wang, et al.
Page
of 5